Survodutide
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
Boehringer Ingelheim · Phase 1 · Active, not recruiting · Enrollment 64
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Survodutide arm | n/r | n/r | n/r | n/r |
| Semaglutide arm | n/r | n/r | n/r | n/r |
Not shown
- Survodutide arm: endpoint not reported
- Semaglutide arm: endpoint not reported